An update from Veritas In Silico Inc. ( ($JP:130A) ) is now available. Veritas In Silico Inc. and Dexerials Corporation have announced a joint ...
CAMBRIDGE, MA / ACCESS Newswire / / Moderna, Inc. (NASDAQ:MRNA) today announced that the first patient has been dosed in a ...
Backed by fresh European financing, BioNTech’s Kigali facility is emerging as the cornerstone of Africa’s mRNA vaccine ...
allAfrica.com on MSN
South Africa: Biovac Opens New Product Development Laboratory in Cape Town
The Deputy Minister of Science, Technology and Innovation, Dr Nomalungelo Gina, will deliver the keynote address at the opening of Biovac's new product development laboratory in Cape Town on Thursday, ...
Stimulating cancer cells to produce a molecule that activates a signaling pathway in nearby immune cells can force tumors to ...
CastleVax, a clinical-stage biotechnology company developing intranasal vaccines using its attenuated Newcastle Disease Virus (NDV)-based vaccine platform, announced today that the first participant ...
Bizcommunity on MSN
Aspen Pharmacare reaches €25m settlement in mRNA contract dispute
Aspen Pharmacare said it had reached a €25m settlement in a contractual dispute with a client over a manufacturing and ...
Altamira will start offering its xPhore ™ platform for DNA delivery under the specific GenePhore ™ label, complementing its offerings for short RNA (OligoPhore ™), linear mRNA (SemaPhore ... Our ...
In a breakthrough for diagnostics, scientists have created an easy and effective test that identifies a heart failure biomarker in saliva, opening the door to more rapid and accessible life-saving ...
Major change for rare disease treatments on way, signals MHRA: United Kingdom Tuesday, November 4, 2025, 13:00 Hrs [IST] The rulebook for rare disease therapies will be overhauled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback